CD59: Its role in complement regulation and potential for therapeutic use

被引：28

作者：

Sugita, Y ^{[1
]}

Masuho, Y ^{[1
]}

机构：

[1] YAMANOUCHI PHARMACEUT CO LTD, MOLEC MED RES LABS, TSUKUBA, IBARAKI 305, JAPAN

来源：

IMMUNOTECHNOLOGY | 1995年 / 1卷 / 3-4期

关键词：

complement; CD59; MAC;

D O I：

10.1016/1380-2933(95)00018-6

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

CD59 regulates complement activation cascade at the final step, inhibiting formation of membrane attack complex (MAC). This protein, being anchored to the cell membrane via glycosyl phosphatidyl inositol (GPI), is expressed ubiquitously on cells which are in contact with body fluids containing components. Recently, MAC formation has been reported to play an important role in pathogenesis of inflammatory diseases such as ischemia or autoimmune diseases. In this review, we describe the structure and biological activities of CD59, the pathogenic role of MAC formation, and discuss application of soluble molecules of CD59 for therapeutic use.

引用

页码：157 / 168

页数：12

共 114 条

[1] STRUCTURE AND FUNCTION OF THE COMPLEMENT RECEPTORS, CR-1 (CD35) AND CR-2 (CD21) [J].

AHEARN, JM ;

FEARON, DT .

ADVANCES IN IMMUNOLOGY, 1989, 46 :183-219

[2]

BAKER PJ, 1989, AM J PATHOL, V135, P185

[3] TERMINAL COMPLEMENT PROTEINS C5B-9 RELEASE BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR FROM ENDOTHELIAL-CELLS [J].

BENZAQUEN, LR ;

NICHOLSONWELLER, A ;

HALPERIN, JA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :985-992

[4]

BIESECKER G, 1989, J IMMUNOL, V142, P2654

[5] THE INFLUENCE OF TUMOR-NECROSIS-FACTOR-ALPHA, INTERLEUKIN-1-BETA AND INTERFERON-GAMMA ON THE EXPRESSION AND FUNCTION OF THE COMPLEMENT REGULATORY PROTEIN CD59 ON THE HUMAN COLONIC ADENOCARCINOMA CELL-LINE HT29 [J].

BJORGE, L ;

JENSEN, TS ;

ULVESTAD, E ;

VEDELER, CA ;

MATRE, R .

SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (04) :350-356

[6] CD59 EXPRESSED BY HUMAN ENDOTHELIAL-CELLS FUNCTIONS AS A PROTECTIVE MOLECULE AGAINST COMPLEMENT-MEDIATED LYSIS [J].

BROOIMANS, RA ;

VANDERARK, AAJ ;

TOMITA, M ;

VANES, LA ;

DAHA, MR .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (03) :791-797

[7] RELATIVE ROLES OF DECAY-ACCELERATING FACTOR, MEMBRANE COFACTOR PROTEIN, AND CD59 IN THE PROTECTION OF HUMAN ENDOTHELIAL-CELLS AGAINST COMPLEMENT-MEDIATED LYSIS [J].

BROOIMANS, RA ;

VANWIERINGEN, PAM ;

VANES, LA ;

DAHA, MR .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (12) :3135-3140

[8]

BUTIKOFER P, 1989, BLOOD, V74, P1481

[9] ROLE OF THE MEMBRANE ATTACK COMPLEX OF COMPLEMENT IN LUNG INJURY MEDIATED BY ANTIBODIES TO ENDOTHELIUM [J].

CAMUSSI, G ;

BIESECKER, G ;

CALDWELL, PRB ;

BIANCONE, L ;

ANDRES, G ;

BRENTJENS, JR .

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1993, 102 (03) :216-223

[10]

CARNEY DF, 1990, J IMMUNOL, V145, P623

← 1 2 3 4 5 6 7 8 9 10 →